TTD_Target_ID	Target_Name	TTD_Drug_ID	Drug_Name	Drug_Highest_Status	Drug_PubchemID	Molecular_Formula	Molecular_Weight	Canonical_SMILES	Activity	Binder_Type
T98091	Inflammation-related GPCR EX33	B10ZUI	2-(4-Phenylbutylsulfanyl)-4-(trifluoromethyl)-1H-pyrimidin-6-one	Investigative	137205241	C15H15F3N2OS	328.4	C1=CC=C(C=C1)CCCCSC2=NC(=CC(=O)N2)C(F)(F)F	EC50 ~ 100000 nM	Poor binder
T98091	Inflammation-related GPCR EX33	B1QK4C	10-Hydroxylauric acid	Investigative	10176767	C12H24O3	216.32	CCC(CCCCCCCCC(=O)O)O	EC50 ~ 100000 nM	Poor binder
T98091	Inflammation-related GPCR EX33	B2B5SG	2-(Hexylthio)-6-hydroxy-3-methyl-4(3H)-pyrimidinone	Investigative	135458798	C11H18N2O2S	242.34	CCCCCCSC1=NC(=CC(=O)N1C)O	EC50 ~ 100000 nM	Poor binder
T98091	Inflammation-related GPCR EX33	B2BZ0A	11-Hydroxylauric acid	Investigative	169433	C12H24O3	216.32	CC(CCCCCCCCCC(=O)O)O	EC50 ~ 100000 nM	Poor binder
T98091	Inflammation-related GPCR EX33	B2MJL9	2-Hexylsulfanyl-4-(7-hydroxyheptoxy)-1H-pyrimidin-6-one	Investigative	127045484	C17H30N2O3S	342.5	CCCCCCSC1=NC(=CC(=O)N1)OCCCCCCCO	EC50 ~ 100000 nM	Poor binder
T98091	Inflammation-related GPCR EX33	B2Y9QK	6-Hydroxydodecanoic acid	Investigative	37289	C12H24O3	216.32	CCCCCCC(CCCCC(=O)O)O	EC50 ~ 100000 nM	Poor binder
T98091	Inflammation-related GPCR EX33	B63LWR	4-Hydroxy-2-(8-hydroxyoctylsulfanyl)-1H-pyrimidin-6-one	Investigative	127045483	C12H20N2O3S	272.37	C1=C(N=C(NC1=O)SCCCCCCCCO)O	EC50 ~ 100000 nM	Poor binder
T98091	Inflammation-related GPCR EX33	B6LAI1	4-Hydroxy-5-methyl-2-(4-phenylbutylsulfanyl)-1H-pyrimidin-6-one	Investigative	127044147	C15H18N2O2S	290.4	CC1=C(N=C(NC1=O)SCCCCC2=CC=CC=C2)O	EC50 ~ 100000 nM	Poor binder
T98091	Inflammation-related GPCR EX33	B78EMP	4-Amino-2-(4-phenylbutylsulfanyl)-1H-pyrimidin-6-one	Investigative	136986925	C14H17N3OS	275.37	C1=CC=C(C=C1)CCCCSC2=NC(=CC(=O)N2)N	EC50 ~ 100000 nM	Poor binder
T98091	Inflammation-related GPCR EX33	B9I2EC	6-Hexyloxy-2-hexylsulfanyl-pyrimidin-4-ol	Investigative	127045328	C16H28N2O2S	312.5	CCCCCCOC1=CC(=O)NC(=N1)SCCCCCC	EC50 ~ 100000 nM	Poor binder
T98091	Inflammation-related GPCR EX33	BG7T5M	9-Hydroxy-dodecanoic acid	Investigative	5312744	C12H24O3	216.32	CCCC(CCCCCCCC(=O)O)O	EC50 ~ 100000 nM	Poor binder
T98091	Inflammation-related GPCR EX33	BG8RK7	7-Hydroxylauric acid	Investigative	5312743	C12H24O3	216.32	CCCCCC(CCCCCC(=O)O)O	EC50 ~ 100000 nM	Poor binder
T98091	Inflammation-related GPCR EX33	BH0QF6	2-(4-Phenylbutylsulfanyl)pyrimidine-4,6-diamine	Investigative	114333799	C14H18N4S	274.39	C1=CC=C(C=C1)CCCCSC2=NC(=CC(=N2)N)N	EC50 ~ 100000 nM	Poor binder
T98091	Inflammation-related GPCR EX33	BH7TB8	5-(4-Hydroxy-6-oxo-1H-pyrimidin-2-yl)pentanenitrile	Investigative	127043659	C9H11N3O2	193.2	C1=C(N=C(NC1=O)CCCCC#N)O	EC50 ~ 100000 nM	Poor binder
T98091	Inflammation-related GPCR EX33	BLT36V	5-Hydroxydodecaneoic acid sodium salt	Investigative	102338889	C12H23NaO3	238.3	CCCCCCCC(CCCC(=O)[O-])O.[Na+]	EC50 ~ 100000 nM	Poor binder
T98091	Inflammation-related GPCR EX33	BY2K6V	4-Methyl-2-(4-phenylbutylsulfanyl)-1H-pyrimidin-6-one	Investigative	137205240	C15H18N2OS	274.4	CC1=CC(=O)NC(=N1)SCCCCC2=CC=CC=C2	EC50 ~ 100000 nM	Poor binder
T98091	Inflammation-related GPCR EX33	BY6KI8	8-Hydroxydodecanoic acid	Investigative	14454530	C12H24O3	216.32	CCCCC(CCCCCCC(=O)O)O	EC50 ~ 100000 nM	Poor binder
T98091	Inflammation-related GPCR EX33	BZH14M	3-Benzyl-2-hexylsulfanyl-6-hydroxypyrimidin-4-one	Investigative	137205242	C17H22N2O2S	318.4	CCCCCCSC1=NC(=CC(=O)N1CC2=CC=CC=C2)O	EC50 ~ 100000 nM	Poor binder